文献速递痛风与晶体性关节病自身炎症与 IgG4 相关病

机械敏感性TRPV4通道是晶体诱导炎症所必需的

Mechanosensitive TRPV4 is required for crystal-induced inflammation.
PubMed 文献 · Ann Rheum Dis · 2021-10-18

该研究探讨机械敏感性TRPV4通道在晶体诱导炎症中的作用。研究发现TRPV4在滑膜巨噬细胞和人PBMC中功能性表达,且MSU晶体刺激及急性痛风发作患者PBMC中TRPV4表达上调。遗传缺失或药理抑制TRPV4可显著减轻MSU晶体诱导的痛风性关节炎,机制上TRPV4介导多种晶体(而非非晶体)激活NLRP3炎症小体产生IL-1β,且TRPV1阳性伤害感受器与TRPV4阳性滑膜巨噬细胞的神经免疫交互参与急性痛风发作。

要点

  • TRPV4在滑膜巨噬细胞和人PBMC中功能性表达,MSU晶体刺激及急性痛风患者中表达上调
  • 遗传缺失或药理抑制TRPV4可显著减轻MSU晶体诱导的痛风性关节炎
  • TRPV4通过NLRP3炎症小体介导多种晶体诱导的IL-1β产生,参与神经免疫交互

核心结论

  • TRPV4是多种晶体通过巨噬细胞NLRP3炎症小体激活诱导炎症反应的共同介质。
  • 表达TRPV4的常驻巨噬细胞关键参与MSU晶体诱导的痛风性关节炎。
  • 表达TRPV1的伤害感受器与表达TRPV4的滑膜巨噬细胞之间的神经免疫交互促进急性痛风发作。

研究设计与样本

  • 使用实时RT-PCR、RNAscope原位杂交和Trpv4eGFP小鼠检测TRPV4表达。
  • 采用全细胞膜片钳记录和活细胞Ca2+成像研究小鼠滑膜巨噬细胞和人PBMC中TRPV4功能。
  • 采用遗传缺失和药理抑制方法,在体外及晶体诱导疼痛和炎症小鼠模型中研究TRPV4在NLRP3炎症小体激活中的作用。

主要发现

  • TRPV4在滑膜巨噬细胞和人PBMC中功能性表达。
  • MSU晶体刺激及急性痛风发作患者PBMC中TRPV4表达上调。
  • 遗传缺失或药理抑制TRPV4功能显著减轻MSU晶体诱导的痛风性关节炎。
  • TRPV4介导多种晶体材料(而非非晶体NLRP3炎症小体激活剂)激活NLRP3炎症小体,驱动IL-1β产生。
  • 化学消融表达TRPV1的伤害感受器显著减轻MSU晶体诱导的痛风性关节炎。

临床怎么用

  • TRPV4可能作为晶体诱导炎症(如痛风)的潜在治疗靶点。
  • TRPV4介导的NLRP3炎症小体激活和IL-1β产生是晶体相关炎症的关键环节。
  • 神经免疫交互(TRPV1伤害感受器与TRPV4滑膜巨噬细胞)为急性痛风发作提供干预思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Crystal structures activate innate immune cells, especially macrophages and initiate inflammatory responses. We aimed to understand the role of the mechanosensitive TRPV4 channel in crystal-induced inflammation. Real-time RT-PCR, RNAscope in situ hybridisation, and Trpv4eGFP mice were used to examine TRPV4 expression and whole-cell patch-clamp recording and live-cell Ca2+ imaging were used to study TRPV4 function in mouse synovial macrophages and human peripheral blood mononuclear cells (PBMCs). Both genetic deletion and pharmacological inhibition approaches were used to investigate the role of TRPV4 in NLRP3 inflammasome activation induced by diverse crystals in vitro and in mouse models of crystal-induced pain and inflammation in vivo. TRPV4 was functionally expressed by synovial macrophages and human PBMCs and TRPV4 expression was upregulated by stimulation with monosodium urate (MSU) crystals and in human PBMCs from patients with acute gout flares. MSU crystal-induced gouty arthritis were significantly reduced by either genetic ablation or pharmacological inhibition of TRPV4 function. Mechanistically, TRPV4 mediated the activation of NLRP3 inflammasome by diverse crystalline materials but not non-crystalline NLRP3 inflammasome activators, driving the production of inflammatory cytokine interleukin-1β which elicited TRPV4-dependent inflammatory responses in vivo. Moreover, chemical ablation of the TRPV1-expressing nociceptors significantly attenuated the MSU crystal-induced gouty arthritis. In conclusion, TRPV4 is a common mediator of inflammatory responses induced by diverse crystals through NLRP3 inflammasome activation in macrophages. TRPV4-expressing resident macrophages are critically involved in MSU crystal-induced gouty arthritis. A neuroimmune interaction between the TRPV1-expressing nociceptors and the TRPV4-expressing synovial macrophages contributes to the generation of acute gout flares.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Lan Z, Chen L, Feng J, et al. Mechanosensitive TRPV4 is required for crystal-induced inflammation. Ann Rheum Dis. 2021. PMID: 34663597. doi:10.1136/annrheumdis-2021-220295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。